Blick ins Buch

Direct Oral Anticoagulants (eBook)

From Pharmacology to Clinical Practice

Riccardo Proietti, Ahmed AlTurki, Nicola Ferri, Vincenzo Russo, T. Jared Bunch (Herausgeber)

eBook Download: PDF

2021 | 1st ed. 2021
VI, 283 Seiten
Springer International Publishing (Verlag)
978-3-030-74462-5 (ISBN)

Lese- und Medienproben

Ebook-Leseprobe (PDF)

This book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease and cancer, including their perioperative management.

Direct Oral Anticoagulants: From Pharmacology to Clinical Practice systematically describes the underlying mechanisms associated with DOACs and their use to treat a range of conditions and is an indispensable resource for all trainee and practicing physicians in a range of disciplines seeking a concise up-to-date resource on the topic.

Dr. Riccardo Proietti MD, PhD, graduated at the Catholic University of Rome in 1997. He then specialized in cardiology at the University of Perugia and achieved a PhD degree in Cardiovascular Science at the University of Padua. He accomplished a fellowship in clinical electrophysiology at McGill University Canada. Since 2010, he is Consultant Cardiologist at Luigi Sacco Hospital of Milan with main activity in cardiac pacing and electrophysiology. He is certified in cardiac pacing by the European Heart Rhythm society and in Clinical Electrophysiology by the Heart Rhythm Society. He is author of articles in national and international peer-reviewed journals and a number of book chapters.

Ahmed AlTurki completed internal medicine residency and a fellowship in cardiology at McGill University in Montreal, Canada and is currently undertaking a fellowship in cardiac electrophysiology at the same institution. His main scientific interests include oral anticoagulation for atrial fibrillation, cardiac implantable electronic devices and catheter ablation of atrial fibrillation. He has authored over peer-reviewed journal articles and several book chapters.

Nicola Ferri is Associate Professor in Pharmacology at the University of Padua. His main scientific interest is focused on drugs affecting lipid metabolism and atherosclerosis. He received several honours, among all the award 'Giovani Ricercatori' by Italian Society for the study of atherosclerosis (SISA). He is elected in the organizing committee of the European Lipoprotein Club meeting (from 2017 until 2011) and of SISA Veneto section (from 2018-2022). He is authors of more than 100 peer-review manuscripts.

Vincenzo Russo undertook specialist training in Cardiology at Monaldi Hospital. He earned PhD degree in Pathophysiology of the Cardio-Respiratory System from Second University of Naples in 2013. Since 2010, Dr. Russo serves as Consultant Cardiologist at Monaldi Hospital in Naples and as Honorary Fellow in Cardiovascular Diseases at School of Medicine - University of Campania 'Luigi Vanvitelli'. He has published over 100 peer-reviewed manuscripts and is an editor for Cardiology Research and Practice.

T. Jared Bunch completed internal medicine residency and fellowships in cardiovascular diseases and electrophysiology at the Mayo Clinic in Rochester Minnesota. He received the Mayo Brothers Distinguished Fellowship Award for clinical care of patients and the Donald C. Balfour Award for meritorious research. He served as an Assistant Professor of Medicine at the Mayo Clinic from 2003-2007, before joining his current partners at Intermountain Heart Rhythm Specialists. He currently directs heart rhythm research at Intermountain Medical Center and is the medical director for heart rhythm services of Intermountain Healthcare. He is involved in multiple national and international trials involving cardiac rhythm management. He has published over 100 manuscripts and 10 book chapters. He is the Editor-in-Chief of Heart Rhythm Case Reports and a section editor for Heart Rhythm.

Erscheint lt. Verlag	28.6.2021
Zusatzinfo	VI, 283 p. 36 illus., 34 illus. in color.
Sprache	englisch
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie
Schlagworte	Apixaban • Atrial Fibrillation • Dabigatran • direct oral anticoagulants • DOAC • Edoxaban • Non-Vitamin K Antagonists • Rivaroxaban • stroke prevention
ISBN-10	3-030-74462-0 / 3030744620
ISBN-13	978-3-030-74462-5 / 9783030744625

Haben Sie eine Frage zum Produkt?

PDF (Wasserzeichen)
Größe: 5,7 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Print-Ausgabe

Buch | Hardcover

160,49 €